Skip to main content
. 2022 Jan 19;167:125–132. doi: 10.1016/j.amjcard.2021.11.054

Table 2.

In-hospital cardiovascular and no cardiovascular complications stratified according to combinations of normal/elevated NPs and troponin levels (n = 341)

COMBINATION OF NPs AND Troponin LEVELS
NPs/Tn N NPs–/Tn– (n = 97) N NPs–/Tn+ (n = 46) N NPs+/Tn– (n = 67) N NPs+/Tn+ (n = 131) p value
Cardiovascular complication 83 11 (13%) 43 8 (19%) 64 19 (30%) 123 50 (41%) <0.001
Onset of atrial fibrillation 68 4 (6%) 25 4 (16%) 55 9 (16%) 94 18 (19%) 0.115
Atrial fibrillation at discharge 64 3 (5%) 18 3 (17%) 50 5 (10%) 79 18 (23%) 0.014
STEMI 93 0 (0%) 43 0 (0%) 67 0 (0%) 130 5 (4%) 0.089
Heart failure 83 1 (1%) 43 1 (2%) 63 6 (10%) 118 27 (23%) <0.001
Pulmonary embolism 93 4 (4%) 43 3 (7%) 67 6 (9%) 130 12 (9%) 0.541
Stroke 93 0 (0%) 43 1 (2%) 67 0 (0%) 130 1 (1%) 0.359
Major bleeding 83 3 (4%) 43 2 (5%) 63 2 (3%) 118 12 (10%) 0.198
No cardiovascular complication 93 19 (20%) 44 9 (21%) 67 15 (22%) 130 42 (32%) 0.147
Sepsis 93 11 (12%) 43 5 (12%) 67 13 (19%) 128 18 (14%) 0.541
Acute renal insufficiency 80 6 (8%) 41 4 (10%) 59 6 (10%) 104 27 (26%) 0.002
Multiorgan failure 76 0 (0%) 38 1 (3%) 59 3 (5%) 103 11 (11%) 0.008

NP = natriuretic peptide; Tn = troponin; STEMI = ST-elevation myocardial infarction.

Data shown as median (IQR)., or count (%).